HHL-U:CA:TSX-Harvest Healthcare Leaders Income ETF (USD)

ETF | Others |

Last Closing

CAD 8.65

Change

-0.03 (-0.35)%

Market Cap

N/A

Volume

3.20K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

-0.23 (-0.66%)

CAD 6.64B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.38 (-1.33%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 5.91B
PHYS-U:CA Sprott Physical Gold Trust

-0.30 (-1.32%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.59 (-1.58%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

-0.59 (-1.27%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.46 (-1.72%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.17 (-1.58%)

CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

-0.14 (-0.28%)

CAD 3.24B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.01 (+0.04%)

CAD 2.78B

ETFs Containing HHL-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.75% 89% A- 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.75% 89% A- 81% B-
Trailing 12 Months  
Capital Gain -2.59% 8% B- 17% F
Dividend Return 3.30% 67% D+ 55% F
Total Return 0.71% 8% B- 17% F
Trailing 5 Years  
Capital Gain 18.98% 38% F 46% F
Dividend Return 42.53% 94% A 92% A
Total Return 61.51% 59% D- 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 3.55% 51% F 45% F
Dividend Return 4.33% 53% F 41% F
Total Return 0.78% 79% B- 35% F
Risk Return Profile  
Volatility (Standard Deviation) 7.28% 68% D+ 84% B
Risk Adjusted Return 59.42% 69% C- 68% D+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike